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A novel complex of cadmium (II) picrate (pic) with V-shaped ligand bis(N-allylbenzimidazol-2-ylmethyl)benzylamine (babb),
with composition [Cd(babb)2](pic)2, was synthesized and characterized by elemental analyses and electrical conductivity, IR,
and UV/visible spectra. The crystal structure of the complex has been determined by the single-crystal X-ray diﬀraction. In the
complex, the coordination sphere around Cd (II) is distorted octahedral, six nitrogen atoms involved in coordination aﬀorded
by two tridentate ligand babb. Moreover, The DNA-binding properties of the ligand babb and Cd (II) complex were investigated
by spectrophotometric methods and viscosity measurements, and the results suggest that they bind to DNA via an intercalation
binding mode, and the Cd (II) complex shows higher aﬃnity than the ligand.
1.Introduction
Benzimidazole is a typical heterocyclic ligand with nitrogen
as the donor atom. It may mimic the histidine imidazole in
coordination aspects and it is a component of biologically
important molecules [1]. Due to the privileged structure [2],
benzimidazolesandtheirderivativeshaveattractedgreatdeal
of interests because of their potential application in the area
ofdrugsandpharmaceuticalssuchasantitumor[3],antiviral
[4], anticancer [5], antimicrobial [6], antiprotozoal [7],
and anti-inﬂammatory or analgesic activities [8]. Besides,
this type of materials was distinctively studied for their
reaction activities and roles as important intermediate in the
inorganic and organic synthesis. Binding studies of small
molecules to DNA are very important in the development
of DNA molecular probes and new therapeutic reagents
[9]. Transition metal complexes have attracted considerable
attention as oxidation catalysts [10], probes in electron-
transfer reactions involving metallo-proteins [11], and inter-
calators with DNA [12]. The studies about transition metal
complexes contribute to further understanding irreplaceable
role of transition metal in vivo [13].
In previous papers [14–17], we have investigated the
coordinating ability of some kind of benzimidazoles lig-
ands. In this paper, we have prepared and investigated
the spectrum properties and crystal structure of the cad-
mium (II) complex with a novel V-shaped ligand bis(N-
allylbenzimidazol-2-ylmethyl)benzylamine (babb). Besides,
we also conduct the related research on the DNA-binding
properties of this compound to investigate the mode of the
complex bond to DNA.
2. Experimental
2.1. Materials and Instruments. T h eC ,H ,a n dNe l e m e n t a l
analyses were determined using a Carlo Erba 1106 elemen-
tal analyzer. Electrolytic conductance measurements were
made with a DDS-307-type conductivity bridge using 3 ×
1−3 molL−1 solutions in DMF at room temperature. The
IR spectra were recorded in the 4000–400cm−1 region with
a Nicolet FT-VERTEX 70 spectrometer using KBr pellets.
Electronic spectra were taken on a Lab-Tech UV Bluestar
spectrophotometer. The ﬂuorescence spectra were recorded
on an LS-45 spectroﬂuorophotometer.2 Bioinorganic Chemistry and Applications
Calf thymus DNA (CT-DNA) and ethidium bromide
(EB) were purchased from Sigma. All chemicals used were
of analytical grade. All the experiments involving interaction
of the ligand and the complexes with CT-DNA were carried
outindoublydistilledwaterbuﬀercontaining5mMTrisand
50mM NaCl and adjusted to pH 7.2 with hydrochloric acid.
A solution of CT-DNA gave a ratio of UV absorbance at 260
and 280nm of about 1.8–1.9, indicating that the CT-DNA
wassuﬃcientlyfreeofprotein[18].TheCT-DNAconcentra-
tion per nucleotide was determined spectrophotometrically
by employing an extinction coeﬃcient of 6600M−1 cm−1 at
260nm [19].
Absorption titration experiments were performed with
ﬁxed concentrations of the complex, while gradually increas-
ing the concentration of CT-DNA. To obtain the absorption
spectra, the required amount of CT-DNA was added to both
compound solution and the reference solution to eliminate
the absorbance of CT-DNA itself. From the absorption
titration data, the binding constant (Kb) was determined
using the equation in [20]
[DNA]
εa −εf
=
[DNA]
εb −εf
+
1
Kb

εb −εf
,( 1 )
where [DNA] is the concentration of CT-DNA in base
pairs, εa corresponds to the extinction coeﬃcient observed
(Aobsd/[M]), εf corresponds to the extinction coeﬃcient of
the free compound εb, is the extinction coeﬃcient of the
compound when fully bound to CT-DNA, and Kb is the
intrinsic binding constant. The ratio of slope to intercept in
the plot of [DNA]/(εa − εf) versus [DNA] gave the value of
Kb.
EB emits intense ﬂuorescence in the presence of CT-
DNA, due to its strong intercalation between the adjacent
CT-DNA base pairs. It was previously reported that the
enhanced ﬂuorescence can be quenched by the addition of a
secondmolecule[21,22].Theextentofﬂuorescencequench-
ing of EB bound to CT-DNA can be used to determine the
extent of binding between the second molecule and CT-
DNA. The competitive binding experiments were carried out
in the buﬀer by keeping [DNA]/[EB] = 1 and varying the
concentrations of the compounds. The ﬂuorescence spectra
of EB were measured using an excitation wavelength of
520nm, and the emission range was set between 550 and
750nm. The spectra were analyzed according to the classical
Stern-Volmer equation in [23]
I0
I
= 1+KSV[Q],( 2 )
where I0 and I are the ﬂuorescence intensities at 599nm in
the absence and presence of the quencher, respectively, KSV is
the linear Stern-Volmer quenching constant, and [Q] is the
concentration of the quencher. In these experiments, [CT-
DNA] = 2.5 × 10−3 mol/L, [EB] = 2.2 × 10−3 mol/L.
Viscosity experiments were conducted on an Ubbelodhe
viscometer, immersed in a water bath maintained at 25.0
± 0.1◦C. Titrations were performed for the complexes (3–
35μM), and each compound was introduced into CT-
DNA solution (50μM) present in the viscometer. Data were
Table 1: Crystallographic data and data collection parameters for
[Cd(babb)2](pic)2.
Complex [Cd(babb)2](pic)2
Molecular formula C70H62CdN16O14
Molecular weight 1463.76
Crystal system Triclinic
Space group P-1
a(˚ A) 13.903 (4)
b(˚ A) 14.146 (4)
c(˚ A) 19.330 (5)
α (◦) 90.595 (3)
β (◦) 110.890 (3)
γ (◦) 106.325 (3)
V (˚ A3) 3382.5 (16)
Z2
ρcald (mgm−3) 1.437
F(000) 1508
Crystal size (mm) 0.40 × 0.38 × 0.30
θ range for data collection (◦) 2.25 to 25.00
h/k/l (max, min) −16, 16/−15, 16/ −22, 22
Reﬂections collected 20103
Independent reﬂections 11730 [R(int) = 0.0253]
Completeness to theta = 25.00 98.4%
Reﬁnement method Full-matrix least-
squares on F2
Data/restraints/parameters 11730/49/910
Goodness-of-ﬁt on F2 1.008
Final R1, wR2 indices [I>2σ(I)] 0.0473, 0.1117
R1, wR2 indices (all data) 0.0682, 0.1249
Largest diﬀerences peak and hole
(e ˚ A−3) 0.986 and −0.537
presented as (η/η0)
1/3 versus the ratio of the concentration of
the compound to CT-DNA, where η is the viscosity of CT-
DNA in the presence of the compound and η0 is the viscosity
of CT-DNA alone. Viscosity values were calculated from
the observed ﬂow time of CT-DNA-containing solutions
correctedfromtheﬂowtimeofbuﬀeralone(t0), η = (t−t0)
[24].
2.2. Compound Preparation
2.2.1. Preparation of the Bis(N-allylbenzimidazol-2-ylmethyl)
benzylamine (babb). The precursor—bis(2-benzimidazol-2-
ylmethyl)benzylamine (bbb) was synthesized following a
slight modiﬁcation of the procedure [25]. 7.34g (20mmol)
bbb with 1.56g (40mmol) potassium in 150mL tetrahydro-
furan followed by adding 4.84g (40mmol) allyl bromide.
The resulting solution was concentrated and recrystal-
lized from ethanol and the pale yellow block crystals were
obtained [26]. Yield: 5.46g (61%); m.p.: 113–115◦C. Anal.
calcd. for C29H29N5: C, 77.82; H, 6.53; N, 15.65. Found: C,Bioinorganic Chemistry and Applications 3
Table 2: Selected atomic distances (˚ A) and bond angles (◦) for the complex.
Bond distances
Cd(1)–N(15) 2.248 (3) Cd(1)–N(13) 2.319 (3)
Cd(1)–N(11) 2.281 (3) Cd(1)–N(7) 2.556 (3)
Cd(1)–N(9) 2.307 (3) Cd(1)–N(12) 2.673 (3)
Bond angles
N(15)–Cd(1)–N(11) 109.41 (11) N(9)–Cd(1)–N(7) 70.12 (10)
N(15)–Cd(1)–N(9) 96.74 (11) N(13)–Cd(1)–N(7) 92.25 (11)
N(11)–Cd(1)–N(9) 106.65 (11) N(15)–Cd(1)–N(12) 70.80 (11)
N(15)–Cd(1)–N(13) 100.72 (12) N(11)–Cd(1)–N(12) 165.10 (10)
N(11)–Cd(1)–N(13) 98.24 (11) N(9)–Cd(1)–N(12) 87.96 (10)
N(9)–Cd(1)–N(13) 142.69 (11) N(13)–Cd(1)–N(12) 67.50 (10)
N(15)–Cd(1)–N(7) 166.37 (10) N(7)–Cd(1)–N(12) 111.11 (9)
N(11)–Cd(1)–N(7) 72.40 (10)
78.02;H,6.35;N,15.71%.IRdata(KBrν/cm−1):737(νo−Ar);
1265 (νC−N); 1461 (νC=N), 1614 (νC=C).
2.2.2. Preparation of [Cd(babb)2](pic)2. To a stirred solution
of babb (223.5mg, 0.5mmol) in hot EtOH (10mL) was
added cadmium (II) picrate (142.15mg, 0.25mmol) in
EtOH (5mL). A yellow crystalline product which formed
rapidly was ﬁltered oﬀ, washed with EtOH and absolute
Et2O, and dried in vacuo. The dried precipitate was dissolved
in acetonitrile resulting in a yellow solution that was
allowed to evaporate at room temperature. Pale yellow
crystals suitable for X-ray diﬀraction studies were obtained
after two weeks. Yield: 269mg (67%). Anal. calcd. for
C70H62CdN16O14 (MW1463.76):C,69.14;H,5.80;N,13.90.
Found: C, 69.33; H, 5.71; N, 13.79%. ΛM (DMF, 297K):
135.67Scm2 mol−1.I Rd a t a( K B rν/cm−1): 746 (νo−Ar); 1288
(νC−N); 1479 (νC=N), 1633 (νC=C).
2.2.3. X-Ray Structure Determination. A suitable single crys-
tal was mounted on a glass ﬁber and the intensity data were
collected on a Bruker APEX-II CCD diﬀractometer with
graphite-monochromated Mo-Kα radiation (λ = 0.71073 ˚ A)
at 153K. Date reduction and cell reﬁnement were performed
using SAINT programs [27]. The absorption corrections
were carried out by the empirical method. The structure
was solved by direct methods and reﬁned by full-matrix
least-squares against F 2 of data using SHELXTL software
[28]. All H atoms were found in diﬀerence electron density
maps and were subsequently reﬁned in a riding-model
approximation with C–H distances ranging from 0.93 to
0.97 ˚ Aa n dU iso (H) = 1.2U eq (C). Basic crystal data,
description of the diﬀraction experiment, and details of the
structure reﬁnement are given in Table 1. Selected bond
distances and angles are presented in Table 2.
3. Results andDiscussion
The cadmium complex is soluble in DMF, DMSO, and
acetonitrile, but insoluble in methanolethanol and other
organic solvents. The elemental analyses show that the
compositionis[Cd(babb)2](pic)2,whichisthesamewiththe
theoretical ratio. A composition of molar conductance value
shows the 1:2 electrolytes of the complex in DMF with those
previously reported in the literature [29].
3.1. Crystal Structure. The crystal structure of complex
consists of discrete [Cd(babb)2]2+ cation and two picrate
anions. The ORTEP structure of [Cd(babb)2]2+ with atom-
numberings is shown in Figure 1.
The cadmium ion is six-coordinate with an N6 ligand
set. The ligand babb acts as a tridentate N-donor. The
coordination geometry of the Cd (II) may be best described
as distorted octahedral with (N9, N11, N12, N13) from an
equatorial plane. In the four selected nitrogen atoms, the
maximum deviation distance (N13) from the least square
plane calculated from the four N atoms is 0.321 (3) ˚ A,
which indicated four selected coordination nitrogen atoms
almost in a plane. The bond angle of the two atoms
(N7, N15) in axial positions is 166.37(10)◦ ˚ A, and the
distances deviation from the plane are 2.100 ˚ A and 2.395 ˚ A,
respectively. Therefore, compared with a regular octahedron,
it reﬂects a relatively distorted coordination octahedron
around Cd (II) [30].
3.2. IR and UV-Visible Spectra. In the free ligand, a strong
band is found around 1265cm−1 along with a medium
band at 1461cm−1. By analogy with the assigned bands
of imidazole, the former is attributed to υC−N, while the
other one is υC=N [31–33]. The location of the two bands
occurred slightly migration in the complex, which implies
direct coordination of all four imine nitrogen atoms to Cd
(II) [34]. Information regarding the possible bonding modes
of the picrate and benzimidazole rings also can be obtained
from the IR spectra [35].
DMF solutions of the ligand babb and the complex show,
as expected, that the UV bands of babb (279nm) are only
marginally blue-shifted in the complex, which shows clear
evidence of C=N coordination to cadmium. The absorption
bands are assigned to π → π∗ (imidazole) [36]. This
conclusion is conﬁrmed by the result of the crystal structure
analysis.4 Bioinorganic Chemistry and Applications
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Figure 1: Molecular structure and atom-numberings of [Cd(babb)2]2+ with hydrogen atoms omitted for clarity.
3.3. Absorption Titration. The absorption titration experi-
ment was carried out to investigate the binding aﬃnity of
the complexes with CT-DNA. A complex bound to DNA
through intercalation is characterized by hypochromism
in absorbance and red shift in wavelength, due to the
intercalation mode involving a strong stacking interaction
between the aromatic chromophore and the DNA base pairs
[37]. A certain amount of hypochromism is commonly
consistent with the strength of the intercalative interaction
[38–40]. The intrinsic binding constants Kb of the complexes
with DNA were obtained by monitoring the changes in
absorbance at 270–280nm for the complex with increasing
concentration of DNA. The absorption spectral titration of
the complex binding to DNA was performed by increasing
a certain amount of DNA (5μL) to complex in Tris-HCl
buﬀer. The sample solution was scanned in the range of 200–
500nm. The constant (Kb) was obtained by the following
equation [20]: [DNA]/(εa − εf) = [DNA]/(εb − εf)+1 /Kb
(εb − εf), apparent absorption coeﬃcient εa, εf,a n dεb
correspondtoAobsd/[M],theextinctioncoeﬃcientofthefree
complex and the extinction coeﬃcient of the complex when
fully bound to DNA, respectively. In plots of [DNA]/(εa −
εf) versus [DNA], Kb is given by the ratio of slope to the
intercept.
The absorption spectra of the ligand babb and Cd (II)
complex in the absence and presence of DNA at diﬀerent
concentrations are given in Figure 2. With increasing DNA
concentrations, the hypochromisms are 18.26% at 275nm
for babb and 50.29% at 280nm for Cd (II) complex. The
λmax for ligand babb and Cd (II) complex increased from
275 to 276nm, 276 to 278nm, respectively. The Kb values
of babb, Cd (II) complex were 2.26 × 103 M−1 (R = 0.98
for 15 points), 1.46 × 105 M−1 (R = 0.99 for 16 points),
respectively. The results may be suggested that the ligand
babb and Cd (II) complex bind to DNA via the intercalation
mode, involving strong π → π∗ stacking interactions
between benzimidazole rings of the compounds and DNA
base pairs, and the binding strength of Cd (II) complex is
greater than the ligand.
3.4. EB Competitive Experiment. No luminescence was ob-
served for the complex at room temperature in any organic
solvent or in the presence of CT-DNA. So the binding of
complexes with CT-DNA cannot be directly presented in
the emission spectra. Therefore, competitive EB binding
studies could be undertaken in order to examine the binding
of each complex with DNA. EB (ethidium bromide) is
a conjugate planar molecule. Its ﬂuorescence intensity is
very weak in solvent, but it is greatly increased when EB
is speciﬁcally intercalated into the base pairs of double-
stranded DNA. In previous studies, the ﬂuorescent light
could be quenched by the addition of the complex which can
compete with EB to bind with DNA. This is a proof that the
complexes intercalate to base pairs of DNA [41]. The Stern-
Volmer quenching constant KSV is often used to evaluate theBioinorganic Chemistry and Applications 5
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Figure 2: Absorption spectra of the ligand babb (a), Cd (II) complex (c) (3 × 10−5 molL−1) in the absence and presence of increasing
amounts of DNA (0–15 × 10−5 mol L−1) in 5mmol L−1 Tris-HCl/50mmol L−1 NaCl buﬀer (pH = 7.2). The arrow shows absorbance changes
on increasing DNA concentration. Plot of [DNA]/(εa − εf) versus [DNA] for absorption titration of DNA with the ligand babb (b), Cd (II)
complex (d).
quenchingeﬃciencyforeachcomplexanddeterminedbythe
classical Stern-Volmer equation [23]:
I0
I
= 1+KSV[Q]. (3)
I0 and I are the ﬂuorescence intensities in the absence
and presence of the quencher, respectively, and [Q] is the
concentration of the complex.
It was clear that the ﬂuorescence intensity of EB-DNA
system greatly decreases upon the addition of the complexes
(5μL) gradually. The ﬂuorescence quenching of EB-DNA by
thecomplexisshowninFigure 3.TheStern-Volmerconstant
KSV isobtainedastheslopeofI0/I versuscomplexlinearplot.
From Figure 3, the KSV values for the ligand babb and Cd
(II) complex are 1.44 × 104 M−1 (R = 0.98 for 13 points)
and 3.50 × 104 M−1 (R = 0.98 for 7 points in the linear
part), respectively. The results suggest that the ligand babb
and Cd (II) complex can compete for DNA-binding sites
with EB and displace EB from the EB-DNA system [42],
which is usually characteristic of the intercalative interaction
ofcompoundswithDNA[43].Additionally,Thedatasuggest
that the interaction of the Cd (II) complex with CT-DNA is
strongerthanthatoftheligandbabb,whichisconsistentwith
the above absorption spectral results.
3.5.ViscosityMeasurement. Furtherclariﬁcationoftheinter-
actions between the Cd (II) complex and DNA was carried
out by viscosity measurements. Due to its sensitivity to the
change of length of DNA, viscosity measurement may be
the most eﬀective means to study the binding mode of6 Bioinorganic Chemistry and Applications
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Figure 3: Emission spectra of EB bound to CT-DNA in the presence of the ligand babb (a), Cd (II) complex (c), [Complex] = 3 × 10−5 M;
λex = 520nm. The arrows show the intensity changes upon increasing concentrations of the complex. Fluorescence quenching curves of EB
bound to CT-DNA by the ligand babb (b), Cd (II) complex (d). (Plots of I0/I versus [Complex].)
complex to DNA [22]. A signiﬁcant increase in the viscosity
of DNA on the addition of the compounds indicates the
intercalative mode of binding to DNA. In contrast, complex
that binds in the DNA grooves by partial and/or nonclassical
intercalationcauseslesspronounced(positiveornegative)or
no change in DNA solution viscosity [40]. Titrations were
performed for the compounds (3–35μM), and the complex
was introduced into the CT-DNA solution (50μM) present
in the viscometer. Viscosity values were calculated from
the observed ﬂow time of CT-DNA containing solutions
c o r r e c t e df r o mt h eﬂ o wt i m eo fb u ﬀer alone (t0), η =
(t − t0)/t0 [44]. Data were presented as (η/η0)
1/3 versus
the ratio of the concentration of the complex to CT-DNA,
where η is the viscosity of CT-DNA in the presence of the
complex and η0 is the viscosity of CT-DNA alone. Viscosity
measurements were carried out on CT-DNA by varying the
concentration of the compound. Figure 4 shows the ligand
babb and Cd (II) complex cause increase in the relative
viscosity of DNA. This may be explained by the fact that they
both can intercalate the adjacent DNA base pairs, leading to
an increase in the separation of base pairs at intercalation
sitesand,thus,anincreaseinoverallDNAcontourlength.So
the results demonstrate that the complex could bind to DNA
by intercalation mode, which is consistent with the above
absorption and ﬂuorescence spectral results.
4. Conclusions
In this paper, a new ligand babb and its Cd (II) complex
have been synthesized and characterized. The DNA-bindingBioinorganic Chemistry and Applications 7
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Figure 4: Eﬀect of increasing amounts of the ligand babb (a), Cd (II) complex (b) on the relative viscosity of CT-DNA at 25 (±0.1)◦Ci n
5mmolL−1 Tris-HCl buﬀer (pH = 7.2, [DNA] = 5 × 10−5 M).
properties of the ligand babb and Cd (II) complex were
investigated by electronic absorption, ﬂuorescence, and
viscosity measurements. The results indicate that they both
can bond to CT-DNA in an intercalation mode and the Cd
(II)complexshowshigheraﬃnitythanthefreeligand,which
can be attributed to the more planar structure owing to
upon coordination to the metal. The results can provide the
evidence for designing the drugs and pharmaceuticals on a
molecular level and warrant further in vivo experiments and
pharmacological assays.
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